RecruitingPhase 3NCT07263308

Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2

Sponsor

Capital Medical University

Enrollment

1,192 participants

Start Date

Dec 18, 2025

Study Type

INTERVENTIONAL

Conditions

Acute Ischemic Stroke

Summary

This study is a prospective, multicenter, open-label, randomized controlled clinical trial. The investigators will apply albumin to the reperfusion treatment of patients with acute ischemic stroke in the anterior circulation. This study aims to verify the efficacy and safety of albumin combined with endovascular treatment in patients with anterior circulation acute ischemic stroke.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Albumin and a procedure called Endovascular treatment for people with acute ischemic stroke. The study is currently recruiting participants at 12 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAlbumin

25% human albumin at a dose of 0.5g/kg (maximum dose 37.5g) should be administered intravenously. On the second, third, and fourth days, 25% human albumin at a dose of 0.5g/kg (maximum dose 37.5g) should be administered daily.

PROCEDUREEndovascular treatment

Best endovascular treatment.

Locations(12)

Taihe County Hospital of Traditional Chinese Medicine

Fuyang, Anhui, China

Si County People's Hospital

Suzhou, Anhui, China

Xuanwu Hospital，Capital Medical University

Beijing, Beijing Municipality, China

Shanghai General Hospital Jiujuan Hospital

Jiuquan, Gansu, China

Gansu Provincial Hospital

Lanzhou, Gansu, China

Jixi People's Hospital

Jixi, Heilongjiang, China

Ningling County People's Hospital

Shangqiu, Henan, China

The First Affiliated Hospital of Xinxiang Medical University

Weihui, Henan, China

The First Affiliated Hospital of Henan University of Chinese Medicine

Zhengzhou, Henan, China

Zhongmou County People's Hospital

Zhengzhou, Henan, China

Rizhao Hospital of Traditional Chinese Medicine

Rizhao, Shandong, China

Laizhou People's Hospital

Yantai, Shandong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07263308

Related Trials

Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy

NCT070496922 locations

A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

NCT07361302246 locations

REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)

NCT075999042 locations

Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the M2 Segment of Middle Cerebral Artery

NCT073476653 locations

Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease

NCT072999948 locations